STOCKSCREENR

ABBV vs MRK

Comparing AbbVie Inc. (ABBV) and Merck & Co., Inc. (MRK) across valuation, profitability, financial health, growth, performance, and analyst metrics. Both companies operate in the Healthcare sector.

Price & Valuation

ABBV
Metric
MRK
$226.11
Price
$116.05
$399.80B
Market Cap
$286.92B
95.41
P/E Ratio
15.94
-125.29
P/B Ratio
5.48
6.65
P/S Ratio
4.40
1.24
PEG Ratio
-4.13
0.00
EV/EBITDA
35.69

Profitability

ABBV
Metric
MRK
$2.37
EPS
$7.28
-3.62%
ROE (TTM)
+0.36%
+0.03%
ROA (TTM)
+0.13%
+0.73%
Gross Margin
+0.82%
+0.27%
Operating Margin
+0.41%
+0.11%
Net Margin
+0.18%

Financial Health

ABBV
Metric
MRK
-21.06
Debt/Equity
0.96
0.67
Current Ratio
1.54
0.33
Beta
0.26

Dividends

ABBV
Metric
MRK
Dividend Yield
+1.61%
Payout Ratio
+0.71%

Growth

ABBV
Metric
MRK
+83.02%
EPS Growth (YoY)
-0.19%
+0.09%
Revenue Growth (YoY)
+0.07%

Performance

ABBV
Metric
MRK
-1.18%
1 Day
-0.42%
+3.82%
1 Month
+5.99%
-0.84%
YTD
+10.05%
1 Year

Analyst

ABBV
Metric
MRK
Analyst Score
2.00
$255.83
Target Consensus
$122.42

This side-by-side comparison of AbbVie Inc. (ABBV) and Merck & Co., Inc. (MRK) covers key financial metrics including valuation ratios, profitability margins, balance sheet strength, dividend yields, growth rates, price performance, and analyst consensus. Green-highlighted values indicate the "winner" for each metric — higher is better for profitability and growth metrics, while lower is better for valuation and risk metrics. Use the free stock screener to compare any stocks across dozens of fundamental and technical filters.